🚀 VC round data is live in beta, check it out!
Deltex Medical Group Valuation Multiples
Discover revenue and EBITDA valuation multiples for Deltex Medical Group and similar public comparables like JETEMA Co., SANUWAVE Health, Inogen, Vuno and more.
Deltex Medical Group Overview
About Deltex Medical Group
Deltex Medical Group PLC is a British manufacturer of Fluid Management devices, which include the ODM and now ODM+ haemodynamic monitoring systems. The company has developed the gold standard for haemodynamic monitoring with oesophageal Doppler technology, which is marketed as TrueVue Doppler and often generically referred to by clinicians as ODM. The company's initial and principal technology is Doppler-based ultrasound oesophageal haemodynamic monitoring.
Founded
2000
HQ
Employees
37
Website
Sectors
Financials (FY)
EV
$183M
Deltex Medical Group Financials
Deltex Medical Group reported last fiscal year revenue of $2M and negative EBITDA of ($1M).
In the same fiscal year, Deltex Medical Group generated $2M in gross profit, ($1M) in EBITDA losses, and had net loss of ($2M).
Deltex Medical Group P&L
In the most recent fiscal year, Deltex Medical Group reported revenue of $2M and EBITDA of ($1M).
Deltex Medical Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $2M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $2M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 63% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($1M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (52%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (48%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($2M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (72%) | XXX | XXX | XXX |
| Net Debt | — | — | $1M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Deltex Medical Group Stock Performance
Deltex Medical Group has current market cap of $181M, and enterprise value of $183M.
Market Cap Evolution
Deltex Medical Group's stock price is $0.10.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $183M | $181M | 0.0% | XXX | XXX | XXX | $-0.00 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialDeltex Medical Group Valuation Multiples
Deltex Medical Group trades at 76.1x EV/Revenue multiple, and (147.1x) EV/EBITDA.
Deltex Medical Group Financial Valuation Multiples
As of April 19, 2026, Deltex Medical Group has market cap of $181M and EV of $183M.
Equity research analysts estimate Deltex Medical Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Deltex Medical Group has a P/E ratio of (104.1x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $181M | XXX | $181M | XXX | XXX | XXX |
| EV (current) | $183M | XXX | $183M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 76.1x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (147.1x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (157.5x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 120.1x | XXX | XXX | XXX |
| P/E | — | XXX | (104.1x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (86.4x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Deltex Medical Group Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Deltex Medical Group Margins & Growth Rates
Deltex Medical Group's revenue in the last fiscal year grew by —.
Deltex Medical Group's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Deltex Medical Group Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA Margin | — | XXX | (52%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 39% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 61% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 12% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 112% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Deltex Medical Group Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Deltex Medical Group | XXX | XXX | XXX | XXX | XXX | XXX |
| JETEMA Co. | XXX | XXX | XXX | XXX | XXX | XXX |
| SANUWAVE Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Inogen | XXX | XXX | XXX | XXX | XXX | XXX |
| Vuno | XXX | XXX | XXX | XXX | XXX | XXX |
| Pro-Dex | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Deltex Medical Group M&A Activity
Deltex Medical Group acquired XXX companies to date.
Last acquisition by Deltex Medical Group was on XXXXXXXX, XXXXX. Deltex Medical Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Deltex Medical Group
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialDeltex Medical Group Investment Activity
Deltex Medical Group invested in XXX companies to date.
Deltex Medical Group made its latest investment on XXXXXXXX, XXXXX. Deltex Medical Group invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Deltex Medical Group
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Deltex Medical Group
| When was Deltex Medical Group founded? | Deltex Medical Group was founded in 2000. |
| Where is Deltex Medical Group headquartered? | Deltex Medical Group is headquartered in United Kingdom. |
| How many employees does Deltex Medical Group have? | As of today, Deltex Medical Group has over 37 employees. |
| Who is the CEO of Deltex Medical Group? | Deltex Medical Group's CEO is Andrew Jonathan Mears. |
| Is Deltex Medical Group publicly listed? | Yes, Deltex Medical Group is a public company listed on OTC Pink Sheets. |
| What is the stock symbol of Deltex Medical Group? | Deltex Medical Group trades under DTXMF ticker. |
| When did Deltex Medical Group go public? | Deltex Medical Group went public in 2009. |
| Who are competitors of Deltex Medical Group? | Deltex Medical Group main competitors are JETEMA Co., SANUWAVE Health, Inogen, Vuno. |
| What is the current market cap of Deltex Medical Group? | Deltex Medical Group's current market cap is $181M. |
| What is the current revenue of Deltex Medical Group? | Deltex Medical Group's last fiscal year revenue is $2M. |
| What is the current EV/Revenue multiple of Deltex Medical Group? | Current revenue multiple of Deltex Medical Group is 76.1x. |
| Is Deltex Medical Group profitable? | No, Deltex Medical Group is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.